Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Study on the Synthetic Lethal Mechanism of Selective Killing of ALDH2 Deficient Acute Myeloid Leukemia Cells By Inhibiting BRIP1

Jishi Wang, Xiuying Hu

Blood (2023) 142 (Supplement 1): 7142.

https://doi.org/10.1182/blood-2023-188050

Published: 2023

Journal Articles

CD56briCD27+CD11b+/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Ming Ni, Peng Zhao, Qian Kang, Chengyun Pan, Xiuying Hu, Tianzhen Hu, Qin Fang, Jishi Wang

Blood (2023) 142 (Supplement 1): 7011.

https://doi.org/10.1182/blood-2023-185534

Published: 2023

Journal Articles

RAB22A As a Predictor of Exosome Secretion in the Progression and Relapse of Multiple Myeloma

Bingjie Fan, Jishi Wang

Blood (2023) 142 (Supplement 1): 3338.

https://doi.org/10.1182/blood-2023-185357

Published: 2023

Journal Articles

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Blood (2023) 142 (Supplement 1): 1900.

https://doi.org/10.1182/blood-2023-183071

Published: 2023

Journal Articles

Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia：Updated Results from a Phase I Study

Blood (2023) 142 (Supplement 1): 4281.

https://doi.org/10.1182/blood-2023-188961

Published: 2023

Journal Articles

BRG1 Regulates Adult B-Cell Acute Lymphoblastic Leukemia Proliferation and Apoptosis By Interacting with c-MYC and Activating PI3K/AKT Pathway

Qian Kang, Peng Zhao, Ming Ni, Qin Fang, Jishi Wang

Blood (2023) 142 (Supplement 1): 5725.

https://doi.org/10.1182/blood-2023-185319

Published: 2023

Journal Articles

High Expression Level of MMP7 and Mir-489-3p/MMP7 Axis Associates with Venetoclax Resistance in Acute Myelogenous Leukemia

Li Wang, Jishi Wang

Blood (2023) 142 (Supplement 1): 5768.

https://doi.org/10.1182/blood-2023-186242

Published: 2023

Journal Articles

Overexpression of Nrf2 in Mesenchymal Stem Cells Promotes Migration and Invasion of B- Acute Lymphoblastic Leukemia Cells

Lin Zheng, Chengyun Pan, Qin Shang, Tianzhen Hu, Shuyun Cao, Li Wang, Hong Luo, Weili Wang, Jishi Wang

Blood (2023) 142 (Supplement 1): 5622.

https://doi.org/10.1182/blood-2023-185784

Published: 2023

Journal Articles

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Ruihao Huang, Ting Chen, Sanbin Wang, Jishi Wang, Yi Su, Jing Liu, Peiyan Kong, Cheng Zhang, Lei Gao, Li Gao, Xi Zhang

Blood (2022) 140 (Supplement 1): 7651–7652.

https://doi.org/10.1182/blood-2022-169431

Published: 2022

Journal Articles

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Jia Chen, Yiyang Ding, Xi Zhang, Erlie Jiang, Lin Liu, He Huang, Jiong Hu, Jishi Wang, Yanming Zhang, Myriam Labopin, Irma Khvedelidze, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty, Depei Wu, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 12952–12953.

https://doi.org/10.1182/blood-2022-165709

Published: 2022

Journal Articles

Nrf2 Overexpression Increases Risk of Venetoclax Resistance in Acute Myeloid Leukemia By Promoting Glycolysis

Shuyun Cao, Jishi Wang, Chengyun Pan, Lin Zheng, Qin Shang

Blood (2022) 140 (Supplement 1): 8340.

https://doi.org/10.1182/blood-2022-171050

Published: 2022

Journal Articles

Overexpression of Nrf2 Promotes OGG1 Expression By Activating AKT Signaling Pathway to Mediate Cytarabine Resistance in Acute Myeloid Leukemia Cells

Qin Shang, Chengyun Pan, Xi Zhang, Tonghua Yang, Jishi Wang, Qin Fang

Blood (2022) 140 (Supplement 1): 11480.

https://doi.org/10.1182/blood-2022-163062

Published: 2022

Journal Articles

A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Blood (2022) 140 (Supplement 1): 4045–4046.

https://doi.org/10.1182/blood-2022-155901

Published: 2022

Journal Articles

Heme Oxygenase-1 Inhibition the Cytotoxicity of NK Cells to AML By Downregulating HLA-C

Cheng Feng, Jishi Wang

Blood (2022) 140 (Supplement 1): 11768.

https://doi.org/10.1182/blood-2022-166279

Published: 2022

Journal Articles

The Role and Mechanism of ALDH2 in Regulating Oxidative Phosphorylation and Promoting Chemotherapy Resistance of Leukemia Stem Cells

Xiuying HU, Jishi Wang

Blood (2022) 140 (Supplement 1): 11532.

https://doi.org/10.1182/blood-2022-166406

Published: 2022

Journal Articles

Phase 1 Safety and Dose Escalation of Purinostat Mesylate, a Uniquely Potent and Selective Inhibitor of HDAC I and IIb in Relapsed or Refractory Lymphoma and Multiple Myeloma

Jie Wang, He Li, Linyu Yang, Ailin Zhao, Peng Zhao, Jishi Wang, Jin Xiang, Jia Miao, Li Zheng, Yongsheng Wang, Lijuan Chen, Ting Niu

Blood (2022) 140 (Supplement 1): 6612–6613.

https://doi.org/10.1182/blood-2022-167079

Published: 2022

Journal Articles

Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)

Yuntian Ding, Lei Wang, Ming Ni, Wenjie Gong, Sanmei Wang, Brigitte Neuber, Maria-Luisa Schubert, Tim Sauer, Angela Hückelhoven-Krauss, Thomas Luft, Ute Hegenbart, Stefan Schönland, Volker Eckstein, Jishi Wang, William Hermann Krüger, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt

Blood (2021) 138 (Supplement 1): 1810.

https://doi.org/10.1182/blood-2021-150106

Published: 2021

Journal Articles

Clinical Charactistics of Ph-Negative MPN Patients with Coexistence of JAK2V617F, Calr and MPL Mutation

Dan Ma, PhD, Ping Liu, Chengyun Pan, Bingqing Cheng, Yaming Zhang, Yan Wang, Xiuying Hu, Jishi Wang, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-142096

Published: 2020

Journal Articles

CD56 bri CD27 + CD11b +/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Ming Ni, MD, Peng Zhao, Qian Kang, Mei Zhao, Min Liu, Fengqi Zhang, Shisi Huang, Dan Ma, PhD, Yaming Zhang, Jiangyuan Zhao, Jishi Wang, PhD

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-141881

Published: 2020

Journal Articles

Inhibition of Heme Oxygenase-1 Attenuates Bortezomib Resistance in Multiple Myeloma Via Down-Regulating Gas6 Production

Zhaoyuan Zhang, Weili Wang, MD, Jie Xiong, PhD, Xingyi Kuang, PhD, Dan Ma, MD, Jishi Wang, PhD

Blood (2019) 134 (Supplement_1): 1781.

https://doi.org/10.1182/blood-2019-130474

Published: 2019

NARROW

Study on the Synthetic Lethal Mechanism of Selective Killing of ALDH2 Deficient Acute Myeloid Leukemia Cells By Inhibiting BRIP1

CD56briCD27+CD11b+/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

RAB22A As a Predictor of Exosome Secretion in the Progression and Relapse of Multiple Myeloma

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia：Updated Results from a Phase I Study

BRG1 Regulates Adult B-Cell Acute Lymphoblastic Leukemia Proliferation and Apoptosis By Interacting with c-MYC and Activating PI3K/AKT Pathway

High Expression Level of MMP7 and Mir-489-3p/MMP7 Axis Associates with Venetoclax Resistance in Acute Myelogenous Leukemia

Overexpression of Nrf2 in Mesenchymal Stem Cells Promotes Migration and Invasion of B- Acute Lymphoblastic Leukemia Cells

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Nrf2 Overexpression Increases Risk of Venetoclax Resistance in Acute Myeloid Leukemia By Promoting Glycolysis

Overexpression of Nrf2 Promotes OGG1 Expression By Activating AKT Signaling Pathway to Mediate Cytarabine Resistance in Acute Myeloid Leukemia Cells

A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Heme Oxygenase-1 Inhibition the Cytotoxicity of NK Cells to AML By Downregulating HLA-C

The Role and Mechanism of ALDH2 in Regulating Oxidative Phosphorylation and Promoting Chemotherapy Resistance of Leukemia Stem Cells

Phase 1 Safety and Dose Escalation of Purinostat Mesylate, a Uniquely Potent and Selective Inhibitor of HDAC I and IIb in Relapsed or Refractory Lymphoma and Multiple Myeloma

Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)

Clinical Charactistics of Ph-Negative MPN Patients with Coexistence of JAK2V617F, Calr and MPL Mutation

CD56 bri CD27 + CD11b +/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Inhibition of Heme Oxygenase-1 Attenuates Bortezomib Resistance in Multiple Myeloma Via Down-Regulating Gas6 Production

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only